trending Market Intelligence /marketintelligence/en/news-insights/trending/hXpeLuHcbdY4f4JJGg-Z_g2 content esgSubNav
In This List

Interleukin board member to resign

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Interleukin board member to resign

Roger Colman is resigning from the Interleukin Genetics Inc. board on Dec. 30.

He was nominated by Pyxis Innovations Inc. following an investment in Interleukin Genetics. Colman is also retiring from Pyxis.

Pyxis Innovations can appoint two directors to the Interleukin Genetics board but is waiving off its right to name a replacement for Colman.

Joseph Landstra continues to represent Pyxis on the Interleukin board.